Compounds > cimetidine

cimetidine and vecuronium bromide

cimetidine has been researched along with vecuronium bromide in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (28.57)	18.7374
1990's	1 (14.29)	18.2507
2000's	2 (28.57)	29.6817
2010's	2 (28.57)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lombardo, F; Obach, RS; Waters, NJ	1
Giacomini, KM; Huang, Y; Khuri, N; Kido, Y; Kosaka, A; Morrissey, KM; Sali, A; Wittwer, MB; Zhang, X; Zur, AA	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Elliott, P; McCarthy, G; Mirakhur, RK; Wright, J	1
Tryba, M; Wruck, G	1
Ulsamer, B	1
Honda, K; Inomata, S; Nakamura, T; Tanaka, E	1

Trials

3 trial(s) available for cimetidine and vecuronium bromide

Article	Year
Effect of H2-receptor antagonist pretreatment on vecuronium- and atracurium-induced neuromuscular block. British journal of anaesthesia, 1991, Volume: 66, Issue:6 Topics: Administration, Oral; Adolescent; Adult; Aged; Atracurium; Cimetidine; Double-Blind Method; Drug Interactions; Histamine H2 Antagonists; Humans; Middle Aged; Nerve Block; Neuromuscular Junction; Premedication; Ranitidine; Time Factors; Vecuronium Bromide	1991
[Interactions of H2 antagonists and non-depolarizing muscle relaxants]. Der Anaesthesist, 1989, Volume: 38, Issue:5 Topics: Adult; Cimetidine; Drug Synergism; Female; Histamine H2 Antagonists; Humans; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Ranitidine; Vecuronium Bromide	1989
[Vecuronium bromide: modification of its pharmacodynamics by etomidate, cimetidine and ranitidine]. Der Anaesthesist, 1988, Volume: 37, Issue:8 Topics: Adult; Cimetidine; Clinical Trials as Topic; Drug Interactions; Etomidate; Female; Humans; Male; Middle Aged; Random Allocation; Ranitidine; Time Factors; Vecuronium Bromide	1988

Other Studies

4 other study(ies) available for cimetidine and vecuronium bromide

Article	Year
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling. Journal of medicinal chemistry, 2013, Feb-14, Volume: 56, Issue:3 Topics: Computer Simulation; Fluorescent Dyes; Organic Cation Transport Proteins; Prescription Drugs	2013
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Effects of premedication medicines on the formation of the CYP3A4-dependent metabolite of ropivacaine, 2', 6'-Pipecoloxylidide, on human liver microsomes in vitro. Basic & clinical pharmacology & toxicology, 2006, Volume: 98, Issue:2 Topics: Amides; Anesthetics, Local; Bupivacaine; Cells, Cultured; Cimetidine; Clonidine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Diazepam; Drug Interactions; Humans; Lidocaine; Microsomes, Liver; Midazolam; Premedication; Ropivacaine; Thiamylal; Vecuronium Bromide	2006